Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia
暂无分享,去创建一个
[1] S. Lee. COVID-19 Pandemic and Mental Health , 2021 .
[2] A. Egbert,et al. Brain abnormalities in COVID-19 acute/subacute phase: A rapid systematic review , 2020, Brain, Behavior, and Immunity.
[3] R. Bilder,et al. InterOrganizational practice committee recommendations/guidance for teleneuropsychology (TeleNP) in response to the COVID-19 pandemic , 2020, The Clinical neuropsychologist.
[4] P. Gil,et al. Clinical presentation and outcome across age categories among patients with COVID-19 admitted to a Spanish Emergency Department , 2020, European Geriatric Medicine.
[5] Yawen An,et al. Psychological Distress and Its Correlates Among COVID-19 Survivors During Early Convalescence Across Age Groups , 2020, The American Journal of Geriatric Psychiatry.
[6] K. Bhaskaran,et al. Factors associated with COVID-19-related death using OpenSAFELY , 2020, Nature.
[7] Ju-Hyun Kim,et al. Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study , 2020, Neurological Sciences.
[8] Maria Thom,et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings , 2020, Brain : a journal of neurology.
[9] K. Bhaskaran,et al. OpenSAFELY: factors associated with COVID-19 death in 17 million patients , 2020, Nature.
[10] G. Logroscino,et al. Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration During COVID-19 Pandemic: Results from Southern Italy. , 2020, Journal of Alzheimer's disease : JAD.
[11] Xingfen Yang,et al. A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis , 2020, Journal of Infection.
[12] H. Miyashita,et al. Impact of dementia on clinical outcomes in elderly patients with coronavirus 2019 (COVID‐19): an experience in New York , 2020, Geriatrics & gerontology international.
[13] P. Matthews,et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study , 2020, The Lancet Psychiatry.
[14] Lynn Rochester,et al. Research with older people in a world with COVID-19: identification of current and future priorities, challenges and opportunities , 2020, Age and ageing.
[15] D. Rentero,et al. Psychotic symptoms in COVID-19 patients. A retrospective descriptive study , 2020, Psychiatry Research.
[16] D. Melzer,et al. ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank , 2020, medRxiv.
[17] D. Kapogiannis,et al. The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis. , 2020, Journal of Alzheimer's disease : JAD.
[18] Vasuki H. Dandu,et al. Spectrum of neuropsychiatric manifestations in COVID-19 , 2020, Brain, Behavior, and Immunity.
[19] I. Deary,et al. Psychosocial factors and hospitalisations for COVID-19: Prospective cohort study based on a community sample , 2020, Brain, Behavior, and Immunity.
[20] V. Mor,et al. An Illustration of SARS‐CoV‐2 Dissemination Within a Skilled Nursing Facility Using Heat Maps , 2020, Journal of the American Geriatrics Society.
[21] E. Roze,et al. Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection , 2020, Journal of Neurology.
[22] Pardis C Sabeti,et al. Neuropathological Features of Covid-19 , 2020, The New England journal of medicine.
[23] A. Mauleon,et al. Dementia Care in Times of COVID-19: Experience at Fundació ACE in Barcelona, Spain , 2020, Journal of Alzheimer's disease : JAD.
[24] E. Mori,et al. The behavioral pattern of patients with frontotemporal dementia during the COVID-19 pandemic , 2020, International Psychogeriatrics.
[25] C. Lucetti,et al. A complication of coronavirus disease 2019: delirium , 2020, Acta Neurologica Belgica.
[26] M. Cesari,et al. Facing Dementia During the COVID‐19 Outbreak , 2020, Journal of the American Geriatrics Society.
[27] F. Humphries,et al. Functional and cognitive outcomes after COVID-19 delirium , 2020, European Geriatric Medicine.
[28] P. Ricci,et al. The silent deaths of the elderly in long-term care facilities during the Covid-19 pandemic: The role of forensic pathology , 2020, The Medico-legal journal.
[29] M. Heneka,et al. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease , 2020, Alzheimer's Research & Therapy.
[30] R. Garg,et al. Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline , 2020, Journal of the Neurological Sciences.
[31] M. Benros,et al. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence , 2020, Brain, Behavior, and Immunity.
[32] N. Manjunatha,et al. Neuropsychiatric aspects of COVID-19 pandemic: A selective review , 2020, Asian Journal of Psychiatry.
[33] R. Pinzon,et al. Neurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis , 2020, Frontiers in Neurology.
[34] S. Farhadian,et al. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. , 2020, JAMA neurology.
[35] H. Geerts,et al. Salvaging CNS Clinical Trials Halted Due to COVID‐19 , 2020, CPT: Pharmacometrics & Systems Pharmacology.
[36] T. Segura,et al. Neurologic manifestations in hospitalized patients with COVID-19 , 2020, Neurology.
[37] Hanqing Liu,et al. Correlation between immune response and self-reported depression during convalescence from COVID-19 , 2020, Brain, Behavior, and Immunity.
[38] I. Benítez,et al. Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer’s disease during the COVID‐19 lockdown , 2020, European journal of neurology.
[39] C. Lucchinetti,et al. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology , 2020, Acta Neuropathologica.
[40] Ebru Temiz,et al. Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research. , 2020, Current neurovascular research.
[41] C. Tsai,et al. The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review , 2020, Frontiers in Neurology.
[42] S. Arnold,et al. Clinical Trials and Tribulations in the COVID-19 Era , 2020, The American Journal of Geriatric Psychiatry.
[43] Paolo Fusar-Poli,et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic , 2020, The Lancet Psychiatry.
[44] W. McDonald,et al. Altered Mental Status as a Novel Initial Clinical Presentation for COVID-19 Infection in the Elderly , 2020, The American Journal of Geriatric Psychiatry.
[45] M. Trabucchi,et al. Clinical Presentation of COVID19 in Dementia Patients , 2020, The journal of nutrition, health & aging.
[46] Victor G. Puelles,et al. Multiorgan and Renal Tropism of SARS-CoV-2 , 2020, The New England journal of medicine.
[47] N. Mercuri,et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection , 2020, Brain, Behavior, and Immunity.
[48] Emre Kara,et al. The another side of COVID‐19 in Alzheimer’s disease patients: Drug‐drug interactions , 2020, International journal of clinical practice.
[49] N. Trotta,et al. Early postmortem brain MRI findings in COVID-19 non-survivors , 2020, Neurology.
[50] M. T. Medina,et al. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries , 2020, Journal of the Neurological Sciences.
[51] J. Higgins,et al. COVID-19 in Older People: A Rapid Clinical Review , 2020, Age and ageing.
[52] Grégory Dal Bo,et al. How to detect and track chronic neurologic sequelae of COVID-19? Use of auditory brainstem responses and neuroimaging for long-term patient follow-up , 2020, Brain, Behavior, & Immunity - Health.
[53] Antonio Cuesta-Vargas,et al. Telehealth Home Support During COVID-19 Confinement for Community-Dwelling Older Adults With Mild Cognitive Impairment or Mild Dementia: Survey Study , 2020, Journal of medical Internet research.
[54] Bernard Harmegnies,et al. Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019 , 2020, Journal of internal medicine.
[55] G. Gao,et al. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 , 2020, Journal of Allergy and Clinical Immunology.
[56] J. Sejvar,et al. Neurological associations of COVID-19 , 2020, The Lancet Neurology.
[57] Ashlyn M Jendro,et al. Facetime to reduce behavioral problems in a nursing home resident with Alzheimer's dementia during COVID-19 , 2020, Psychiatry Research.
[58] M. Bo,et al. Atypical Presentation of Covid-19 in an Older Adult With Severe Alzheimer Disease , 2020, The American Journal of Geriatric Psychiatry.
[59] B. Pollock,et al. Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias , 2020, The American Journal of Geriatric Psychiatry.
[60] M. Fiorino,et al. Access to Care for Dementia Patients Suffering From COVID-19 , 2020, The American Journal of Geriatric Psychiatry.
[61] S. Kremer,et al. Neurologic Features in Severe SARS-CoV-2 Infection , 2020, The New England journal of medicine.
[62] T. Jiang,et al. The differential psychological distress of populations affected by the COVID-19 pandemic , 2020, Brain, Behavior, and Immunity.
[63] J. Kohn,et al. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms , 2020, Brain, Behavior, and Immunity.
[64] S. Merler,et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 2020, JAMA.
[65] Ana Marusic,et al. Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis , 2020, Journal of clinical medicine.
[66] T. Rea,et al. Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington , 2020, The New England journal of medicine.
[67] Taojiao Wang,et al. Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. , 2020, The Journal of clinical investigation.
[68] Sharukh Lokhandwala,et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. , 2020, JAMA.
[69] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[70] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[71] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[72] E. Ely,et al. Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms , 2019, Critical Care.
[73] D. Knopman,et al. Systemic inflammation during midlife and cognitive change over 20 years , 2019, Neurology.
[74] Mayur B. Patel,et al. Co-Occurrence of Post-Intensive Care Syndrome Problems Among 406 Survivors of Critical Illness* , 2018, Critical care medicine.
[75] D. Gibson,et al. Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines , 2018, Front. Immunol..
[76] S. Yoo,et al. Psychiatric Findings in Suspected and Confirmed Middle East Respiratory Syndrome Patients Quarantined in Hospital: A Retrospective Chart Analysis , 2018, Psychiatry investigation.
[77] K. Schughart,et al. Long-Term Neuroinflammation Induced by Influenza A Virus Infection and the Impact on Hippocampal Neuron Morphology and Function , 2018, The Journal of Neuroscience.
[78] Martin Knapp,et al. Social isolation, loneliness and health in old age: a scoping review , 2017, Health & social care in the community.
[79] P. Kehoe,et al. Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology , 2016, Alzheimer's Research & Therapy.
[80] T. Rice,et al. Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers , 2016, Intensive Care Medicine.
[81] Timothy B. Smith,et al. Loneliness and Social Isolation as Risk Factors for Mortality , 2015, Perspectives on psychological science : a journal of the Association for Psychological Science.
[82] Robert A Schoevers,et al. Feelings of loneliness, but not social isolation, predict dementia onset: results from the Amsterdam Study of the Elderly (AMSTEL) , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[83] Thomas E Lane,et al. Inflammation induced by infection potentiates tau pathological features in transgenic mice. , 2011, The American journal of pathology.
[84] D. Needham,et al. Long-term complications of critical care , 2011, Critical care medicine.
[85] A. Kong,et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. , 2009, Archives of internal medicine.
[86] M. Tansey,et al. Molecular Neurodegeneration BioMed Central Review , 2009 .
[87] E. Lazartigues,et al. Angiotensin‐converting enzyme 2 in the brain: properties and future directions , 2008, Journal of neurochemistry.
[88] David K. Meyerholz,et al. Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2 , 2008, Journal of Virology.
[89] G. Almazan,et al. Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice , 2006, Virology.
[90] R. Hopkins,et al. Brain atrophy and cognitive impairment in survivors of acute respiratory distress syndrome , 2006, Brain injury.
[91] J. Koenigsknecht-Talboo,et al. Microglial Phagocytosis Induced by Fibrillar β-Amyloid and IgGs Are Differentially Regulated by Proinflammatory Cytokines , 2005, The Journal of Neuroscience.
[92] Karen J. Chan,et al. Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. , 2005, American journal of respiratory and critical care medicine.
[93] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[94] E. Bigler,et al. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. , 1999, American journal of respiratory and critical care medicine.
[95] G. Wilcock,et al. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease , 1997, The Lancet.
[96] A. Silverstein,et al. Neurologic Manifestations in , 1970 .
[97] H. Johnson,et al. A comparison of 'traditional' and multimedia information systems development practices , 2003, Inf. Softw. Technol..
[98] J. Luban. SARS-CoV-2 , 2020 .
[99] N. Fabrizio,et al. Age, gender, and territory of COVID-19 infections and fatalities , 2020 .
[100] K. Demirkan,et al. COVID-19 Drug Interactions , 2020 .
[101] R. Dantzer. Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa. , 2018, Physiological reviews.
[102] A. Ruiz,et al. Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer’s Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study , 2018, The Journal of Prevention of Alzheimer's Disease.
[103] T. Dunning,et al. Long-Term Complications , 2008 .